The Obesity ETF
Data updated: 2020-03-25
C000169985 — The Obesity ETF. Money Market · $11.91M AUM · 0.35% expense ratio. Holdings, fees, performance and SEC filings.
C000169985 Fund Overview
The Obesity ETF is a US ETF managed by Janus Detroit Street Trust, categorised as Money Market. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US ETF
- Manager: Janus Detroit Street Trust
- Category: Money Market
- Assets under management: $11.91M
- SEC CIK: 0001500604
- SEC series ID: S000054083
- Share class ID: C000169985
C000169985 Investment Objective and Strategy
The Obesity ETF describes its objective and strategy as follows, from its latest prospectus filed with the SEC by Janus Detroit Street Trust.
Investment objective
The Obesity ETF seeks investment results that correspond generally to the performance, before fees and expenses, of an index which is designed to track the performance of companies globally that are positioned to profit from servicing the obese, including biotechnology, pharmaceutical, health care and medical device companies whose business is focused on obesity and obesity related disease including diabetes, high blood pressure, cholesterol, heart disease, stroke, and sleep apnea, and companies focused on weight loss programs, weight loss supplements, or plus sized apparel.
Principal investment strategy
The Fund pursues its investment objective by investing at least 80% of its net assets (plus any borrowings for investment purposes) in the stocks that comprise the Solactive Obesity Index (Underlying Index). The Underlying Index is designed to track the performance of companies globally that are positioned to profit from servicing the obese, including biotechnology, pharmaceutical, health care and medical device companies whose business is focused on obesity and obesity related disease including diabetes, high blood pressure, cholesterol, heart disease, stroke, and sleep apnea, and companies focused on weight loss programs, weight loss supplements, or plus sized apparel. Under normal circumstances, the Fund expects to invest substantially all of its assets in securities included in the Underlying Index, using a replication strategy as discussed below.
The Fund may invest in companies of any capitalization, although at least 90% of the companies will have a capitalization of at least $100 million. The Fund may invest in foreign issuers, including emerging markets. Stocks included in the Underlying Index may include common shares traded on local exchanges, American Depositary Receipts (ADRs) and Global Depositary Receipts (GDRs). ADRs and GDRs represent ownership interests in shares of foreign companies that are held in financial institution custodial accounts, and are traded on exchanges in the United States and around the world. The Fund is classified as nondiversified, which allows it to hold larger positions in a smaller number of companies, compared to a fund that is classified as diversified. The Underlying Index, the Solactive Obesity Index, was created by and is maintained by Solactive AG (Solactive or the Index Provider).
The Underlying Index is reconstituted on a semi-annual basis, rebalanced on a quarterly basis, and the Fund is rebalanced quarterly based on changes to the Underlying Index. The Fund uses a passive, index-based approach in seeking performance that corresponds to the performance of the Underlying Index. The underlying securities are weighted according to their market capitalization relative to other securities in the Underlying Index, and capped so that no security will represent more than 20% of the Underlying Index at the time of an index reconstitution or rebalance. Due to market movement between rebalancing and reconstitution of the Underlying Index, an underlying security may represent more than 20% of the Underlying Index at any given time, and thus may represent more than 20% of the Funds assets at any given time.
The Fund will generally use a replication methodology, meaning it will invest in the securities composing the Underlying Index in proportion to the weightings in the Underlying Index. However, the Fund may utilize a sampling methodology under various circumstances in which it may not be possible or practicable to purchase all of the securities in the Underlying Index. Janus Capital expects that over time, if the Fund has sufficient assets, the correlation between the Funds performance, before fees and expenses, and that of the Underlying Index will be 95% or better. A figure of 100% would indicate perfect correlation. Under normal circumstances, the Fund expects to invest substantially all of its assets in securities included in the Underlying Index, although it may invest up to 20% its assets in other securities that Janus Capital believes will help the Fund track its Underlying Index.
Such investments include stocks, shares of other investment companies, cash and cash equivalents, including money market funds. To the extent the Underlying Index concentrates (i.e., holds 25% or more of its total assets) in the securities of a particular industry or group of industries, the Fund will concentrate its investments to approximately the same extent as its Underlying Index. As of January 31, 2018, approximately 30% and 27% of the Underlying Index was represented by companies in the health care equipment and health care services industries, respectively. For more recent information, see the Funds daily portfolio holdings posted on the ETF portion of the Janus Henderson website. The Fund may lend portfolio securities on a short-term or long-term basis, in an amount equal to up to one-third of its total assets as determined at the time of the loan origination.
C000169985 Costs and Fees
C000169985 costs about $35 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.35%
- Gross expense ratio: 0.35%
- Portfolio turnover: 22%
- Brokerage commissions: 1.81 bps of average net assets (SEC N-CEN)
C000169985 Cashflows
Over the 12 months to 2020-01, The Obesity ETF had net inflows of $0, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2020-01 | $0 |
| 2019-12 | $0 |
| 2019-11 | $0 |
| 2019-10 | $0 |
| 2019-09 | $0 |
| 2019-08 | $0 |
C000169985 Debt Constituents
No individual debt constituents are reported in The Obesity ETF's latest SEC N-PORT filing.
C000169985 Prospectus and SEC Filings
Official The Obesity ETF filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
- Prospectus (485BPOS) — filed 2020-03-20
- Prospectus (485BPOS) — filed 2019-03-21
- Prospectus (485BPOS) — filed 2018-03-21
- Portfolio holdings (N-PORT) — filed 2020-03-25
- Portfolio holdings (N-PORT) — filed 2019-12-23
- Annual census (N-CEN) — filed 2020-01-14
- Annual census, amended (N-CEN/A) — filed 2019-07-15
Related Funds
Other Money Market funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.